Stockscreener 앱 받기
101.25
1.34%
-1.38
시간 외 거래:
101.25
Nuvalent Inc 주식(NUVL)의 최신 뉴스
UBS reiterates Buy rating on Nuvalent stock, citing Royalty Pharma deal - Investing.com Nigeria
[8-K] Nuvalent, Inc. Reports Material Event | NUVL SEC FilingForm 8-K - Stock Titan
Nuvalent’s Royalty Interest Acquired by Royalty Pharma - TipRanks
Nuvalent Acknowledges Royalty Pharma's Acquisition of Royalty Interest - TradingView — Track All Markets
Royalty Pharma Acquires Royalty Interest in Nuvalent's Potential Lung Cancer Therapies - marketscreener.com
Royalty Pharma acquires royalty interest in Nuvalent's neladalkib and zidesamtinib for up to $315 million - marketscreener.com
Royalty Pharma Acquires Royalty Interest in Nuvalent's Neladalkib and Zidesamtinib for Up to $315 Million - Quiver Quantitative
Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million - marketscreener.com
Royalty Pharma (Nasdaq: RPRX) buys Nuvalent NSCLC royalties for up to $315M - Stock Titan
Nuvalent announces public offering of common stock - MSN
Nuvalent, Inc. $NUVL Shares Acquired by Braidwell LP - MarketBeat
Is Nuvalent Inc stock a defensive play in 2025Trade Analysis Summary & Expert Curated Trade Setup Alerts - moha.gov.vn
Natixis Makes New $1.75 Million Investment in Nuvalent, Inc. $NUVL - MarketBeat
Insider Selling: Nuvalent (NASDAQ:NUVL) CFO Sells 7,084 Shares of Stock - MarketBeat
Nuvalent (NUVL) director discloses RSU and stock option acquisitions - Stock Titan
Nuvalent, Inc. (NUVL) is a buy on lung cancer treatment prospects - MSN
HighVista Strategies LLC Has $3.85 Million Stake in Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent appoints Ron Squarer to board of directors By Investing.com - Investing.com Nigeria
Trading the Move, Not the Narrative: (NUVL) Edition - news.stocktradersdaily.com
Insider Sell Alert: Alexandra Balcom Sells Shares of Nuvalent In - GuruFocus
Nuvalent Appoints Ron Squarer to Board of Directors - GuruFocus
Nuvalent appoints Ron Squarer to board of directors - Investing.com
Nuvalent Insider Sold Shares Worth $781,537, According to a Recent SEC Filing - marketscreener.com
Nuvalent CFO Alexandra Balcom Sells Over 7,000 Shares - TradingView — Track All Markets
Ron Squarer Joins Nuvalent Board as Independent Director - TipRanks
Nuvalent, Inc. Announces Board Changes - TradingView — Track All Markets
Nuvalent (Nasdaq: NUVL) taps Ron Squarer for board as zidesamtinib launch prep builds - Stock Titan
Nuvalent (NUVL) Valuation After FDA Breakthrough Designation and Investor Optimism in Lung Cancer Franchise - Sahm
Nuvalent, Inc. $NUVL Shares Acquired by Walleye Capital LLC - MarketBeat
Stempoint Capital LP Has $4.57 Million Stake in Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent’s Clinical and Financial Momentum Captivates Investors - AD HOC NEWS
Nuvalent (NUVL) price target increased by 11.46% to 142.80 - MSN
Ron Squarer joins Nuvalent board as independent director - MSN
Nuvalent, Inc. (NUVL) is a Buy On lung Cancer Treatment Prospects - Insider Monkey
CFO Balcom Files To Sell 7,084 Of Nuvalent Inc [NUVL] - TradingView — Track All Markets
Norges Bank Buys Shares of 374,597 Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent, Inc. (NASDAQ:NUVL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Nuvalent (NUVL) Price Target Increased by 11.46% to 142.80 - Nasdaq
Affinity Asset Advisors LLC Reduces Position in Nuvalent, Inc. $NUVL - MarketBeat
Russell Investments Group Ltd. Sells 28,747 Shares of Nuvalent, Inc. $NUVL - MarketBeat
Rhumbline Advisers Has $5.04 Million Stock Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Layoff Watch: Is Nuvalent Inc stock trading at a premium valuationEarnings Growth Summary & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
NUVL: Late-stage oncology assets show strong efficacy and safety, with first approvals targeted for 2026 - TradingView
Will Nuvalent Inc. stock attract more institutional investorsMarket Sentiment Summary & Long-Term Safe Investment Ideas - Newser
Nuvalent Insider Sold Shares Worth $434,319, According to a Recent SEC Filing - marketscreener.com
Nuvalent Chief Development Officer Sells Shares - TradingView — Track All Markets
Officer Noci Sells 4,000 ($434.3K) Of Nuvalent Inc [NUVL] - TradingView — Track All Markets
Nuvalent (NUVL) Stock Analysis Report | Financials & Insights - Benzinga
American Century Companies Inc. Boosts Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Creative Planning Buys 9,079 Shares of Nuvalent, Inc. $NUVL - MarketBeat
(NUVL) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Returns Recap: Is Nuvalent Inc. stock trading near support levelsJuly 2025 Volume & Long Hold Capital Preservation Tips - BỘ NỘI VỤ
Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress
Nuvalent (NASDAQ:NUVL) Director Sells $639,814.50 in Stock - MarketBeat
Does Nuvalent’s Recent Trial Success Justify the Stock’s 36% 2025 Rally? - Yahoo Finance
Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results (PR Newswire) - Aktiellt
Nuvalent Director and 10% Owner Matthew Shair Sells 7,500 Shares - TradingView
0.18%
0.62%
자본화:
|
볼륨(24시간):